Jump to content

Pfizer-BioNTech vaccine could be ready for approval by mid-October -- but there are still 'unknowns'


perugu_vada

Recommended Posts

https://www.cnn.com/2020/09/08/health/pfizer-biontech-vaccine-october-intl-grm/index.html

Pfizer and BioNTech are confident they can have a vaccine against the novel coronavirus ready for regulatory approval by the middle of October or early November, BioNTech CEO and co-founder Ugur Sahin told CNN Tuesday.

"It has an excellent profile and I consider this vaccine ... near perfect, and which has a near perfect profile," Sahin said in an exclusive interview with CNN.
US drug giant Pfizer and German firm BioNTech say they plan to provide 100 million doses of their vaccine candidate, BNT162, by the end of the year, and up to 1.3 billion doses in 2021.
 
Sahin claims antibody responses in both young adults and the elderly have proven to be strong so far, with minimal side-effects.
"We don't see frequent fever. So only a minor proportion of participants in this trial have fever," Sahin said. "We see also much lower symptoms like headache or like feeling tired. And the symptoms that are observed with such vaccines are temporary, they are usually observed for one or two days and then are gone."
Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
×
  • Create New...